Soleus Capital Management, L.P.

Position in TNGX — Tango Therapeutics, Inc.

CIK 1802630 GREENWICH, CT

Position in TNGX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$9,414,000

+$9,325,400 QoQ

Shares Held

450,000

+4400.0% QoQ

Ownership

0.311%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,422,770,178 across 59 Biotechnology names. TNGX ranks #29 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	1,153,087	$297,865,433
2	CELC	Celcuity Inc.	1,284,378	$146,598,904
3	TGTX	Tg Therapeutics, Inc.	4,029,319	$133,853,977
4	PRAX	Praxis Precision Medicines, Inc.	330,517	$106,489,272
5	VCEL	Vericel Corp	2,549,079	$82,003,871
6	GERN	Geron Corp	41,508,659	$61,847,901
7	IMUX	Immunic, Inc.	4,500,000	$49,950,000
8	EWTX	Edgewise Therapeutics, Inc.	1,449,915	$45,672,322

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,414,000	450,000	+4400.0%	Shares	Sole	2026-05-14
2025-12-31	$88,600	10,000	-96.7%	Shares	Sole	2026-02-12
2025-09-30	$2,520,000	300,000	-58.9%	Shares	Sole	2025-11-14
2025-06-30	$3,737,600	730,000	+112.7%	Shares	Sole	2025-08-15
2024-09-30	$2,642,270	343,152	-67.3%	Shares	Sole	2024-11-14
2024-06-30	$9,008,099	1,049,895	-22.2%	Shares	Sole	2024-08-14
2024-03-31	$10,720,151	1,350,145	+59.4%	Shares	Sole	2024-05-15
2023-12-31	$8,386,735	847,145	-56.1%	Shares	Sole	2024-02-14
2023-09-30	$21,720,753	1,929,019	+8.6%	Shares	Sole	2023-11-14
2023-06-30	$5,899,298	1,776,897	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.